Table 1 Patient Characteristics

From: Risk stratification at prediabetes onset and association with diabetes outcomes using EHR data

 

All Patients

Cohort

Prediabetes onset patients with PD-onset HbA1c Group

Training Cohort.(2018–2020)

Test Cohort.(2021–2022)

Low PD-onset HbA1c.(5.7–5.9%)

High PD-onset HbA1c (6.0–6.4%)

Total

14,436 (28.46%)

7628 (29.94%)

6808 (26.81%)

9449 (18.52%)

4987 (47.30%)

Black

6854 (30.51%)

3971 (30.57%)

2883 (30.42%)

4217 (20.87%)

2637 (45.92%)

Other

2033 (24.89%)

874 (26.43%)

1159 (23.73%)

1372 (15.60%)

661 (44.18%)

White

5549 (27.25%)

2783 (30.15%)

2766 (24.33%)

3860 (16.99%)

1689 (50.68%)

Female

8699 (27.68%)

4492 (28.78%)

4207 (26.50%)

5810 (18.42%)

2889 (46.31%)

Male

5737 (29.65%)

3136 (31.60%)

2601 (27.30%)

3639 (18.69%)

2098 (48.67%)

18-39

1967 (31.52%)

910 (30.22%)

1057 (32.64%)

1479 (23.94%)

488 (54.51%)

40-59

5907 (23.75%)

3157 (23.88%)

2750 (23.60%)

3997 (15.26%)

1910 (41.52%)

60-74

4682 (29.24%)

2571 (31.82%)

2111 (26.10%)

2893 (17.49%)

1789 (48.24%)

75+

1880 (38.14%)

990 (44.14%)

890 (31.46%)

1080 (25.93%)

800 (54.62%)

  1. This table displays patient counts by race, gender, and age groups, with data split between Training (2018–2020) and Test (2021–2022) cohorts, and stratified by HbA1c ranges (5.7–5.9% and 6.0–6.4%).
  2. All data includes percentages shown in parentheses, indicating the number of PD-onset patients and progression to diabetes rate within one year.